Company Filing History:
Years Active: 2024
Title: Xuesong Liu: Innovator in Kinase Inhibition
Introduction
Xuesong Liu is a notable inventor based in Anhui, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of kinase inhibitors. His work focuses on addressing critical health issues through innovative therapeutic solutions.
Latest Patents
Xuesong Liu holds a patent for an indazole kinase inhibitor and its uses. The patent describes a kinase inhibitor compound represented by a specific formula, along with its pharmaceutically acceptable salts, solvates, esters, acids, metabolites, or prodrugs. The pharmaceutical composition containing this kinase inhibitor is designed to inhibit the activity of various kinases, including cKIT, FLT3, PDGFRα, PDGFRβ, and VEGFR2. This invention aims to provide methods for preventing or treating disorders related to these kinases, particularly in cases involving mutant forms.
Career Highlights
Xuesong Liu is associated with Therapeutics Science Inc., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on treating serious medical conditions linked to kinase activity.
Collaborations
Xuesong Liu collaborates with several professionals in his field, including Jing Liu and Qingsong Liu. These partnerships enhance the research and development process, fostering innovation and progress in therapeutic solutions.
Conclusion
Xuesong Liu's contributions to the field of kinase inhibition exemplify the importance of innovation in addressing complex health challenges. His patent and ongoing work at Therapeutics Science Inc. highlight his commitment to advancing medical science.